Q. Nanocovax, developed by Nanogen Pharmaceutical Biotechnology JSC is a COVID-19 vaccine candidate of which country?
Answer:
Vietnam
Notes:
- Nanocovax is a Vietnamese COVID-19 vaccine candidate developed by Nanogen Pharmaceutical Biotechnology JSC.
- It is a subunit vaccine (SARS?CoV?2 recombinant spike protein with aluminum adjuvant).
- The vaccine requires two doses, the second one being administered 21 days after the first shot.
- It is given by intramuscular injection.